<%= message.delivery.preHeader %> View online
 
Important Safety Information | Prescribing Information
Esperoct antihemophilic factor (recombinant), glycopegylated-exei logo.
Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. See full indication below.
 
Tammy
Tammy turned her hemophilia A diagnosis into a mission
“We need more research surrounding women and why they bleed the way they do.”
– Tammy lives with hemophilia A and uses Esperoct®
 
 Meet Tammy 
Tammy
 
“I’ve heard thousands of times over the years that women can’t have hemophilia…I’ve heard every excuse in the book.”
When Tammy was first diagnosed with hemophilia A, she was thought to be one of just 12 girls who had ever been diagnosed in the United States. She often didn’t receive appropriate treatment for her hemophilia and struggled to get doctors to pay attention to her symptoms.
But when she saw how differently her son’s hemophilia was treated, she learned to powerfully advocate for them both.
 
 
Tammy has hemophilia A and uses Esperoct®
Separator
Separator
  Tammy doing yoga
“My son has never had an issue with not being taken seriously and I’ve had to fight for that every step of the way.”
After a harrowing hospital experience, Tammy made it her mission to step up for herself and for other women living with bleeding disorders. Her journey is inspiring—and if you’re a woman or girl experiencing bleeding symptoms, you may find that you recognize a lot of yourself in her story.
Tammy doing yoga
 
Keep scrolling to learn more
 
Selected Important Safety Information
Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face
 
Feeling inspired by Tammy?
You can self-advocate too.
We created Your Guide to Self-Advocacy to help you track your hemophilia symptoms, discuss them with your doctor, and stand up to receive the care you deserve.
Use the Esperoct® Self-Advocacy Guide to get the right diagnosis and appropriate treatment for your hemophilia A.
 Explore the guide 
Brochure
Brochure
  Photo of two RBCLs, Kendra and Lorie, standing side by side
Looking for resources or people who understand the unique challenges you face?
There’s an entire community dedicated to supporting women and girls living with hemophilia.
Connect with a Rare Blood Community Liaison (RBCL) to find local events, get personalized support, and learn more about treatment options like Esperoct®.
 Find your RBCL 
What is Esperoct®?
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery
  • Esperoct® is not used to treat von Willebrand Disease
Important Safety Information
Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face
What should I tell my healthcare provider before using Esperoct®?
  • Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct®
What are the possible side effects of Esperoct®?
  • Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion
Please click here for Prescribing Information.
Esperoct® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
 
PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579.
UNSUBSCRIBE NOTICE
If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (eg, name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Esperoct® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2025 Novo Nordisk  All rights reserved.  US25ESP00043  August 2025
Novo Nordisk logo.
Novo Nordisk logo.